Liver fibrosis in young patients with transfusion-dependent thalassaemia (TDT), understanding the role of steatosis

Br J Haematol. 2023 Feb;200(4):399-400. doi: 10.1111/bjh.18535. Epub 2022 Oct 27.

Abstract

Using transient elastography Padeniya et al. detected steatosis and fibrosis in a cohort of young heavily iron overloaded patients with transfusion-dependent thalassaemia; steatosis was associated only with increasing body mass index, but not with iron overload and diabetes. Recently, great efforts have been devoted to eliminating or reducing iron overload and hepatitis C infection, which are well-recognised causes of liver damage. Thus, haematologists should be aware that steatosis and probably more complex metabolism alterations may be encountered very early in these patients and could be responsible for further liver damage. Commentary on: Padeniya et al. The association between steatosis and liver damage in transfusion-dependent beta thalassaemia patients. Br J Haematol 2023;200:517-523.

Publication types

  • Comment

MeSH terms

  • Fatty Liver* / complications
  • Fatty Liver* / therapy
  • Humans
  • Iron Overload* / metabolism
  • Liver / metabolism
  • Liver Cirrhosis / etiology
  • Thalassemia* / complications
  • Thalassemia* / metabolism
  • Thalassemia* / therapy
  • beta-Thalassemia* / complications
  • beta-Thalassemia* / metabolism
  • beta-Thalassemia* / therapy